AMASS Botanics
AMASS Botanics Stock 1
Portfolio of premium, high-growth botanic beverages and self care products
There is a newer open investment round for this company - click here to view
Our take:
AMASS carries an eyepopping $75m valuation, or 22x 2020 revenue. In addition, the company just closed (3/3/2021) an $11m convertible note at a $38m valuation cap - less than 3 weeks prior to this round doubling the valuation. AMASS has competition from Haus and other brands attacking online alcohol sales by using low-ABV products to skirt regulations.
Sign up to receive weekly deal alerts and top news
Round Performance
Amount Raised
[]
Average Investment
[]
Average Per Day
[]
# of Investors
[]
Investors vs. Capital Raised
Investment Type
Preferred Stock
Round Valuation
$75,000,000
Minimum Investment
$
499
Price Per Share
$3.8654
Investment Details
Early Bird Perks
Perk description | Perk level (dollars) | Perk level (days) |
|---|
Loading...
No early bird perks for this round!
View early bird perks, company financials, valuation methods, and more
Similar Investments
PADL
Moxi on the Rocks
Revenue Share
